Success Stories: EB1B Petition Approved for a Research Scientist in Louisiana in the Field of Life Sciences
Client’s Testimonial:
Thank you so very much for your help. After a windy journey, we finally landed. I greatly appreciate your help.
General Field: Life Sciences
Position at the Time of Case Filing: Research Scientist
Petitioner: A Private University
Country of Origin: China
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Louisiana
Approval Notice Date: August 12, 2014
Processing Time: 8 Days (Premium Processing Requested)
Case Summary:
At North America Immigration Law Group– WeGreened.com, we recently received an EB1B approval for a Research Scientist in Louisiana in the field of Life Sciences. The beneficiary’s outstanding ability, highly skilled background, and impressive record of achievement provided a strong case for his EB1B petition. His specialized research has focused on chemotherapy for hormone-related breast and prostate cancer. His innovative and ground breaking research work has resulted in better treatment options for the particularly difficult to treat types of cancer, triple negative breast cancer (TNBC) and castration resistant prostate cancer (CRPC). His research work had resulted in at least 10 peer-reviewed scientific articles, one book chapter, one patent, and numerous presentations at national and international conferences. Furthermore, the beneficiary had a total of 48 citations to his work by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also conducted 30 manuscript reviews for at least 10 distinctive, internationally circulated journals. The petitioner in this case was a private university. The significance of the beneficiary’s research is confirmed in the following quote by an independent recommender, “The outstanding translational research that [client] conducted sets him on the very top of our cancer research field. His prestige work on cancer research benefits both researchers and patients, in United States and around the world.” It was our goal to prove that this beneficiary qualified for classification as an outstanding professor or researcher given the international recognition for his outstanding achievements. His petition was approved in just 8 days.

